Julkaisuja

Antipsychotic medications and sleep problems in patients with schizophrenia

Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders

Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia

The impact of rare protein coding genetic variation on adult cognitive function

Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders

Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish
individuals with a psychotic disorder